Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma

Adenocarcinoma of the esophagogastric junction (AEGJ) has an increasing incidence and is associated with limited overall survival. Several studies have tried to identify prognostic factors for AEGJ, although few have described relationships between prognosis and the tumor's size or anatomical location. Thus, this retrospective study evaluated 188 patients with resected locally advanced AEGJ. Tumor location was determined using upper endoscopy, and the following groups were created: E&E + EGJ (distal esophagus, esophagogastric junction, and distal esophagus), EGJ (esophagogastric junction), EGJ + G (esophagogastric junction and proximal stomach), G (proximal stomach), and E + EGJ + G (esophagus to the proximal stomach, including the esophagogastric junction). Other variables of interest were tumor size and differentiation, TNM stage, comorbidities, surgery type, and survival outcomes. Among 188 patients included, 163 were men (86.7%), and the mean age was 64.9 years. Forty-eight (25.6%) patients underwent total gastrectomy and distal esophagectomy, while 140 (74.4%) subtotal esophagectomy with proximal gastrectomy. Presence of comorbidities, tumor size, angiolymphatic and perineural invasion, and pTNM status were different between groups according to tumor location. The mean follow-up period was 47.4 months. The disease-free survival (DFS) rates were as follows: 72.7% (G), 68.0% (E&E + EGJ), 63.4% (EGJ), 57.1% (EGJ + G), and 44.4% (E + EGJ + G), while the overall survival (OS) rates were 81.0% (EGJ + G), 78.8% (G), 64.0% (E&E + EGJ), 54.9% (EGJ), and 48.1% (E + EGJ + G). Multivariate analysis revealed that tumor size of < 5 cm, and tumor location G subgroups were associated with better DFS. High histological grade and advanced pT status were independent factors related to worse OS. In conclusion, the prognosis of AEGJ may be preoperatively predicted by a tumor size of >= 5 cm and its anatomical location.

Palavras-chave

Esophagogastric junction adenocarcinoma, Tumor size, Prognostic factors, Siewert classification, Surgical treatment

URI

https://observatorio.fm.usp.br/handle/OPI/50504

Referências

Al-Batran SE, 2017, JAMA ONCOL, V3, P1237, DOI 10.1001/jamaoncol.2017.0515
Borggreve AS, 2018, ANN NY ACAD SCI, V1434, P192, DOI 10.1111/nyas.13677
CRAANEN ME, 1992, AM J GASTROENTEROL, V87, P572
Holscher AH, 2020, GASTRIC CANCER, V23, P3, DOI 10.1007/s10120-019-01022-x
Japan Esophageal Soc, 2017, ESOPHAGUS-TOKYO, V14, P37, DOI 10.1007/s10388-016-0556-2
Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805
Liu K, 2019, GASTRIC CANCER, V22, P506, DOI 10.1007/s10120-018-0890-2
Rice TW, 2016, DIS ESOPHAGUS, V29, P906, DOI 10.1111/dote.12538
Shridhar R, 2014, ANN SURG ONCOL, V21, P3744, DOI 10.1245/s10434-014-3795-2
Takeda FR, 2020, SURG ONCOL, V33, P30, DOI 10.1016/j.suronc.2019.12.009
Takeda FR, 2020, ANN SURG ONCOL, V27, P1241, DOI 10.1245/s10434-019-07967-8
van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088
Victor CR, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00103

Coleções

Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo